Dr. Bourgeois conducts primary toxicology research and human health, environmental, and occupational exposure and risk assessments/analyses. She designs studies evaluating the adverse effects of industrial chemicals, environmental chemicals and licit/illicit drugs using in silico, in vivo and in vitro models. She has published and presented research on a variety of topics related to the effect of multiple factors on the urinary expression of biomarkers of inflammation, renal failure, oxidative stress, and cardiac dysfunction. Past research activities also include the effect of poly (ADP-ribose) polymerase (PARP) inhibition on chemical induced toxicity. Her current research focuses on elucidating mechanisms of chemical and drug-induced toxicity and studying populations with occupational or environmental exposures to contaminants of known or emerging concern.